Literature DB >> 16647622

Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.

Paolo Verdecchia1, Fabio Angeli, Roberto Gattobigio, Mariagrazia Sardone, Sergio Pede, Gian Paolo Reboldi.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) is a risk marker for stroke and its regression confers protection from stroke. The relationship between serial LVH changes and risk of stroke has never been investigated in a mixed population of hypertensive subjects with and without LVH.
METHODS: In this study, 880 initially untreated hypertensive subjects (mean age 48 years, office blood pressure (BP) 155/98 mm Hg; 24-h BP 137/87 mm Hg) underwent tests including echocardiography and 24-h ambulatory BP monitoring at entry and after a median of 3.5 years, still in the absence of cardiovascular events.
RESULTS: Months or years after the follow-up study, 34 of these subjects developed a first cerebrovascular event (stroke in 21, transient ischemic attack in 13). Event rate (x 100 patients per year) was 0.25 among the subjects who never developed echocardiographic LVH or with regression of LVH, versus 1.16 among the subjects with lack of regression or new development of LVH (log-rank test: P = .00001). Serial electrocardiogram (ECG) changes failed to define groups at different risk. In a Cox analysis, the risk of cerebrovascular events was 2.8 times higher (95% CI: 1.18-6.69) in the subset with lack of regression or new development of LVH than in that with LVH regression or persistently normal LV mass. Such effect was independent of age (P = .001) and 24-h systolic BP (P = .003).
CONCLUSIONS: In a mixed hypertensive population with and without LVH at entry, serial changes in the echocardiographic indexes of LVH predict subsequent cerebrovascular events independently of office and ambulatory BP and other individual risk factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647622     DOI: 10.1016/j.amjhyper.2005.10.018

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

1.  Gender differences in adiponectin modulation of cardiac remodeling in mice deficient in endothelial nitric oxide synthase.

Authors:  Jorge L Durand; Andrea R Nawrocki; Philipp E Scherer; Linda A Jelicks
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

Review 2.  Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling in the Community.

Authors:  Ramachandran S Vasan; Elman Martin Urbina; Ling Jin; Vanessa Xanthakis
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

Review 3.  The hypertensive heart. An integrated understanding informed by imaging.

Authors:  Subha V Raman
Journal:  J Am Coll Cardiol       Date:  2010-01-12       Impact factor: 24.094

4.  [Hypertension and heart].

Authors:  M Hennersdorf; C M Schannwell; W Motz
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

Review 5.  [The heart in hypertension].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

6.  Point-of-care screening for left ventricular hypertrophy and concentric geometry using hand-held cardiac ultrasound in hypertensive patients.

Authors:  Roxana Stoica; Eliot N Heller; Jonathan N Bella
Journal:  Am J Cardiovasc Dis       Date:  2011-06-28

7.  Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals.

Authors:  A Mantovani; G Zoppini; G Targher; G Golia; E Bonora
Journal:  J Endocrinol Invest       Date:  2012-02       Impact factor: 4.256

8.  Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ervin R Fox; Nabhan Alnabhan; Alan D Penman; Kenneth R Butler; Herman A Taylor; Thomas N Skelton; Thomas H Mosley
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

Review 9.  Medical treatment of hypertension in patients with heart failure with preserved ejection fraction.

Authors:  Richard G Kiel; Prakash Deedwania
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 10.  Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand?

Authors:  Gadi Shlomai; Guido Grassi; Ehud Grossman; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-08-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.